Antigen delivery systems (Q35843648)

10 August 2017

1 reference

title

Antigen delivery systems (English)

1 reference

10 August 2017

1

Gideon Kersten

1 reference

10 August 2017

Hoang Hirschberg

2

1 reference

10 August 2017

1 August 2004

1 reference

Expert Review of Vaccines

10 August 2017

1 reference

10 August 2017

3

1 reference

10 August 2017

4

1 reference

10 August 2017

453-462

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

10 August 2017

1 reference

Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Pseudo-ternary phase diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by the lipid-film hydration method

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Protein instability in poly(lactic-co-glycolic acid) microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Enhanced immunogenicity of a hepatitis B virus peptide vaccine using oligosaccharide ester derivative microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Targeting polymerised liposome vaccine carriers to intestinal M cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Mucosal immune responses following oral immunization with rotavirus antigens encapsulated in alginate microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Clinical immunogenicity and tolerance studies of liquid vaccines delivered by jet-injector and a new single-use cartridge (Imule): comparison with standard syringe injection. Imule Investigators Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Needle-free epidermal powder immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Structure of the skin barrier and its modulation by vesicular formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

Safety, immunogenicity, and kinetics of the immune response to a single dose of virosome-formulated hepatitis A vaccine in Thais

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.453

21 January 2018

Identifiers

DOI

10.1586/14760584.3.4.453

1 reference

10 August 2017

1 reference

PubMed ID

15270650